New: our quarterly report on the S&P 500, read from 500 companies’ own filings and calls.
Read the Q3 2026 report
Friday, Nov 20, 2026
Export NVAX’s income statement to Excel — free account
Novavax, Inc.
NVAXNovavax, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $1.1 billion, up 64.7% from fiscal 2024.
- Revenue
- −3.05%
- EPS
- n/m
- Free cash flow
- n/m
- Total debt
- +19.3%
Quarter to September 2026, against a year earlier
7.73
0.00
0.00%
Follow NVAX
Alert me
Where the cash went Q3 FY2026, quarter to Sep 30, 2026
Free cash flow was −$95.3M: capital expenditures were more than operating cash flow. Cash rose by $31.0M. What is a cash flow statement?
- Free cash flow
- −$95.3M
- Returned to shareholders
- $0.00
- Debt, net
- −$2.7M repaid
- Change in cash
- +$31.0M over the period
| Operating cash flow | −94.2 |
|---|---|
| Capital expenditures | −1.0 |
| Free cash flow | −95.3 |
| From investments, net | +128.8 |
| Shares issued, net | +0.7 |
| Debt repaid, net | −2.7 |
| Other | −0.5 |
| Change in cash | 31.0 |
Free cash flow
| Q4 FY25 | Q1 FY26 | Q2 FY26 | Q3 FY26 | |
|---|---|---|---|---|
| Operating cash flow | −$39M | −$32M | −$73M | −$94M |
| Capex | −$1.4M | −$1.3M | −$0.6M | −$1M |
| Free cash flow | −$41M | −$34M | −$73M | −$95M |
Figures in millions of dollars. Free cash flow is operating cash flow less capital expenditures. Investments are purchases less sales of securities; “Other” is what the named lines leave of the change in cash.
| Sep '26 | Jun '26 | Mar '26 | Dec '25 | Older periods | |
|---|---|---|---|---|---|
Net Income |
(31.38) | (53.39) | (9.49) | 17.53 |
+8 more quarters Free account |
Depreciation & Amortization |
3.05 | 3.06 | 3.06 | 5.13 | |
Non Cash Items (Other) |
9.56 | 18.39 | (0.98) | 10.27 | |
Accounts Receivable Change |
(25.21) | 8.87 | 86.24 | (51.94) | |
Change in inventories |
(10.27) | (0.32) | (0.23) | 2.15 | |
Change in payables and accrued liability |
(26.44) | (37.09) | (60.08) | (21.54) | |
Change in other assets and liabilities |
(11.12) | (4.71) | (50.95) | (2.37) | |
Other operating activities |
(2.43) | (7.62) | — | 1.30 | |
Operating Cash Flow |
(94.24) | (72.81) | (32.42) | (39.47) | |
Capital expenditures |
(1.02) | (0.59) | (1.27) | (1.42) | |
Change in intangibles (net) |
— | — | — | (0.17) | |
Short Term Investments Change (Net) |
128.80 | 35.49 | (66.84) | 3.08 | |
Other investing activities |
0.00 | 0.00 | 39.75 | 19.65 | |
Investing cash flow |
127.78 | 34.90 | (28.36) | 20.48 | |
Repayment/Issuance of Debt (Net) |
(2.65) | (0.53) | 45.83 | (6.27) | |
Equity Repurchase (Common, Net) |
0.66 | 1.73 | (8.16) | (0.33) | |
Financing cash flow |
(2.00) | 1.20 | 37.68 | (6.60) | |
Exchange Rate Adjustment |
(0.52) | (0.18) | (0.02) | (1.71) | |
Change in Cash |
31.02 | (36.88) | (23.13) | (27.30) | |
Beginning Cash |
0.00 | 0.00 | 256.05 | 0.00 | |
Ending Cash |
31.02 | (36.88) | 232.93 | (27.30) | |
Stock Based Compensation |
7.96 | 8.09 | 7.72 | 7.97 | |
Dividends Paid (Common) |
0.00 | 0.00 | 0.00 | 0.00 | |
Net Cash/Marketcap |
0.00 | 0.00 | 0.00 | 0.00 | |
Assets Liabilities Change (Total) |
(73.04) | (33.25) | (25.01) | (73.70) | |
Investments Change (Net) |
128.80 | 35.49 | (66.84) | 3.08 | |
Issuance/Purchase of Shares |
0.66 | 1.73 | (8.16) | (0.33) |
In millions of $ except per-share values · columns are period end dates · fundamentals updated Nov 18, 2026